Acetylcholinesterase
5 drugs CNS
2
approved indications
5
Approved Drugs
5
Companies
4
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (5 companies)
✓ All 5 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (4 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
EISAI INC 1 drug
ALPHA COGNITION 1 drug
MMT 1 drug
By Therapeutic Area
CNS 4 drugs
Other 1 drugs
Drugs by Company PRO
EISAI INC 1 drug
ALPHA COGNITION 1 drug
MMT 1 drug
MACLEODS PHARMS LTD 1 drug
AbbVie 1 drug
By Therapeutic Area
CNS 4 drugs
ARICEPT, ZUNVEYL, MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE, NAMZARIC
Other 1 drugs
DUODOTE
Indications Treated
Alzheimer's DiseaseDementiaOrganophosphorus Nerve Agent PoisoningOrganophosphorus Insecticide Poisoning
All Drugs Targeting Acetylcholinesterase
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| ARICEPT | EISAI INC | 1996 | 2 | CNS |
| ZUNVEYL | ALPHA COGNITION | 2024 | 2 | CNS |
| DUODOTE | MMT | 2006 | 2 | |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | MACLEODS PHARMS LTD | 2017 | 1 | CNS |
| NAMZARIC | AbbVie | 2014 | 1 | CNS |